Canadá - inglés - Health Canada

holista health (canada) inc. - cis-linoleic acid (evening primrose oil); gamma-linolenic acid (evening primrose oil); vitamin e (d-alpha tocopherol) - capsule - 360mg; 50mg; 15unit - cis-linoleic acid (evening primrose oil) 360mg; gamma-linolenic acid (evening primrose oil) 50mg; vitamin e (d-alpha tocopherol) 15unit - vitamin e

Canadá - inglés - Health Canada

swiss herbal remedies ltd. - gamma-linolenic acid; oleic acid; cis-linoleic acid; palmitic acid; stearic acid - capsule - 129.72mg; 87.216mg; 215mg; 60.72mg; 20.976mg - gamma-linolenic acid 129.72mg; oleic acid 87.216mg; cis-linoleic acid 215mg; palmitic acid 60.72mg; stearic acid 20.976mg - other nutritional agents

Estados Unidos - inglés - NLM (National Library of Medicine)

anazaohealth corporation - bicisate (unii: 3jxf0z0xoi) (bicisate - unii:3jxf0z0xoi) - bicisate 1.35 mg - tc99m bicisate is indicated as an adjunct to conventional ct or mri imaging in the localization of stroke in patients in whom stroke has already been diagnosed there are no known contraindications for this preparation.

Malta - inglés - Medicines Authority

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents

Malta - inglés - Medicines Authority

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents

Malta - inglés - Medicines Authority

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents

Malta - inglés - Medicines Authority

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/5ml - antineoplastic agents

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - cisplatin 1 mg/ml;   - solution for injection - 1 mg/ml - active: cisplatin 1 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - cisplatin accord injection is indicated for the palliative treatment of: · metastatic non-seminomatous germ cell carcinoma; · advanced-stage refractory ovarian carcinoma; · advanced-stage refractory bladder carcinoma; and · refractory squamous cell carcinoma of the head and neck. it may be used as a single agent or in combination with other chemotherapeutic agents. it may be employed, in appropriate circumstances, in addition to other modalities, e.g. radiotherapy or surgery.

Malta - inglés - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - cisplatin - concentrate for solution for infusion - cisplatin 1 mg - antineoplastic agents

Malta - inglés - Medicines Authority

hospira uk limited - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents